Filing Details

Accession Number:
0001209191-20-036174
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-12 06:59:22
Reporting Period:
2020-06-10
Accepted Time:
2020-06-12 06:59:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
921299 Fibrogen Inc FGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1476151 A Enrique Conterno C/o Fibrogen, Inc.
409 Illinois Street
San Francisco CA 94158
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-10 8,000 $36.29 8,000 No 4 P Indirect By Trust
Common Stock Acquisiton 2020-06-11 19,800 $35.28 27,800 No 4 P Indirect By Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Trust
No 4 P Indirect By Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 60,000 Direct
Footnotes
  1. The shares were purchased in the open market at prices ranging from $35.75 to $36.50. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.
  2. The shares were purchased in the open market at prices ranging from $35.22 to $35.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares purchased at each separate price.